Lack of diagnostic tools to prove erectile dysfunction: Consequences for reimbursement?

Journal of Urology

Volumn 163, Issue 1, 2000, Pages 91-94

  Lehmann, Kurt ^a,b   Eichlisberger, Remy ^a,b   Gasser, Thomas C ^a,b  

^a Kantonsspital Baden   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Diagnostic techniques; Health; Impotence; Insurance; Penile erection; Reimbursement; Urological

Indexed keywords

PROSTAGLANDIN E1;

ADULT; AGED; ARTICLE; COLOR ULTRASOUND FLOWMETRY; ERECTILE DYSFUNCTION; HEALTH CARE COST; HUMAN; INTRACAVERNOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REIMBURSEMENT;

EID: 0033992230     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)67980-3     Document Type: Article

References (33)

1. Feldman, H. A., Goldstein, I., Hatzichristou, D. G. et al: Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol, 151: 54, 1994.
2. National Institutes of Health Consensus Panel on Impotence: Impotence, JAMA, 270: 83, 1993.
3. Linet, O. I. and Ogrinc, F. G.: Efficacy and safety of intracavernosal alprostadil in men with erectile dysfunction. N Engl J Med. 334: 873, 1996.
4. Porst, H.: The rationale for prostaglandin E1 in erectile failure: a survey of worldwide experience. J Urol, 155: 802, 1996.
5. Padma-Nathan, H., Hellstrom, W. J., Kaiser, F. E. et al: Treatment of men with erectile dysfunction with transurethral alprostadil. N Engl J Med, 336: 1, 1997.
6. Goldstein, I., Lue, T. F., Padma-Nathan, H. et al: Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med, 338: 1397, 1998.
7. Lue, T. F.: Impotence: a patient's goal-directed approach to treatment. World J Urol, 8: 67, 1990.
8. Meuleman, E. J. and Diemont, W. L.: Investigation of erectile dysfunction. Diagnostic testing for vascular factors in erectile dysfunction. Urol Clin North Am, 22: 803, 1995.
9. Rosen, R. C., Riley, A., Wagner, G. et al: The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology, 49: 822, 1997.
10. Gasser, T. C. and Lehmann, K.: Male sexual function is more than erection. Lancet, 346: 706, 1995.
11. Spoerri, P. and Lehmann, K.: A concise classification of male sexual dysfunction using the LEOS-system. Unpublished data.
12. Lehmann, K., Casella, R., Eichlisberger, R. et al: Sexuell-und pharmakostimulierte Erektionen sind proportional. Urologe A, 38: 162, 1999.
13. Lehmann, K., John, H., Kacl, G. et al: Variable response to intracavernous PGE1 upon evaluation of erectile dysfunction. Urology, 54: 539, 1999.
14. Lee, B., Sikka, S. C., Randrup, E. R. et al: Standardization of penile blood flow parameters in normal men using intracavernous prostaglandin E1 and visual sexual stimulation. J Urol, 149: 49, 1993.
15. Benson, C. B. and Vickers, M. A.: Sexual impotence caused by vascular disease: diagnosis with duplex sonography. AJR Am J Roentgenol, 153: 1149, 1989.
16. Quam, J. P., King, B. F., James, E. M. et al: Duplex and color Doppler sonographic evaluation of vasculogenic impotence. AJR Am J Roentgenol, 153: 1141, 1989.
17. Rajfer, J.: Editorial: impotence - the quick work-up. J Urol, 156: 1951, 1996.
18. Can't buy me love. Time, 152: 43, 1998.
19. Saenz de Tejada, I., Moroukian, P., Tessier, J. et al: Trabecular smooth muscle modulates the capacitor function of the penis. Studies on a rabbit model. Am J Physiol, 260: H1590, 1991.
20. Benet, A., Melman, A., Seftel, A. et al: Standardization of PGE1 dose in pharmoco-penile duplex ultrasound: a multicenter study. J Urol, suppl., 157: 183, abstract 712, 1997.
21. Sharlip, I. D.: The limitations, accuracy and application of diagnostic tests for vasculogenic impotence. Postgraduate course 35 9769, at annual meeting of American Urological Association, New Orleans, Louisiana, April 12-17, 1997.
22. Sohn, M. H., Seeger, U., Sikora, R. et al: Criteria for examiner-independent nocturnal penile tumescence and rigidity monitoring (NPTR): correlations to invasive diagnostic methods. Int J Impot Res, 5: 59, 1993.
23. Mills, R. D. and Sethia, K. K.: Reproducibility of penile arterial colour duplex ultrasonography. Br J Urol, 78: 109, 1996.
24. Kropman, R. F., Schipper, J., v Oostayen, J. A. et al: The value of increased end diastolic velocity during penile duplex sonography in relation to pathological venous leakage in erectile dysfunction. J Urol, 148: 314, 1992.
25. Montague, D. K., Lakin, M. M., VanderBrug Medendorp, S. et al: Infusion pharmacocavernosometry and nocturnal penile tumescence findings in men with erectile dysfunction. J Urol, 145: 768, 1991.
26. Montague, D. K. and Lakin, M. M.: False diagnoses of venous leak impotence. J Urol, 148: 148, 1992.
27. Rajfer, J., Canan, V., Dorey, F. J. et al: Correlation between penile angiography and duplex scanning of cavernous arteries in impotent men. J Urol, 143: 1128, 1990.
28. Kim, S. C., Moon, Y. T. and Oh, C. H.: Non-visualization versus normal appearance of cavernous arteries on selective internal pudendal pharmaco-angiograms: comparison with duplex scanning, cavernosal artery systolic occlusion pressure and penile brachial index. Br J Urol, 73: 185, 1994.
29. Merckx, L., Gerstenberg, T. C., Da Silva, J. P. et al: A consensus on the normal characteristics of corpus cavernosum EMG. Int J Impot Res, 8: 75, 1996.
30. Levine, L. A. and Lenting, E. L.: Use of nocturnal penile tumescence and rigidity in the evaluation of male erectile dysfunction. Urol Clin North Am, 22: 775, 1995.
31. Pescatori, E. S., Hatzichristou, D. G., Namburi, S. et al: A positive intracavernous injection test implies normal venoocclusive but not necessarily normal arterial function: a hemodynamic study. J Urol, 151: 1209, 1994.
32. Derogatis, L. R. and Laban, M. P.: Psychological assessment measures of human sexual functioning in clinical trials. Int J Impot Res, suppl., 10: S13, 1998.
33. O'Leary, M. P., Fowler, F. J., Lenderking, W. R. et al: A brief male sexual function inventory for urology. Urology, 46: 697, 1995.